Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Aliper

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|March 8, 2014
Genetics and epigenetics of aging and longevityAlexey A Moskalev, Alexander M Aliper, Zeljka Smit-McBride, et al.
Cancer Medicine|April 3, 2014
A role for G-CSF and GM-CSF in nonmyeloid cancersAlexander M Aliper, Victoria P Frieden-Korovkina, Anton Buzdin, et al.
Aging|April 20, 2019
Replicative and radiation-induced aging: a comparison of gene expression profilesAlexander M Aliper, Marine E Bozdaganyan, Philipp S Orekhov, et al.
Oncotarget|October 9, 2014
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerAlexander M Aliper, Victoria P Frieden-Korovkina, Anton Buzdin, et al.
Reproductive Biology and Endocrinology : RB&E|June 15, 2014
Molecular aspects of development and regulation of endometriosisYana B Aznaurova, Marat B Zhumataev, Tiffany K Roberts, et al.
Aging|January 15, 2015
Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cellsAlexander M Aliper, Antonei Benjamin Csoka, Anton Buzdin, et al.
Drug Discovery Today|October 4, 2016
Design of efficient computational workflows for in silico drug repurposingQuentin Vanhaelen, Polina Mamoshina, Alexander M Aliper, et al.
Human Genome Variation|April 16, 2016
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patientsQingsong Zhu, Evgeny Izumchenko, Alexander M Aliper, et al.
Frontiers in Molecular Biosciences|May 20, 2015
The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysisAnton A Buzdin, Alex A Zhavoronkov, Mikhail B Korzinkin, et al.
Oncotarget|November 22, 2014
Signaling pathways activation profiles make better markers of cancer than expression of individual genesNikolay M Borisov, Nadezhda V Terekhanova, Alexander M Aliper, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|March 8, 2014
Genetics and epigenetics of aging and longevityAlexey A Moskalev, Alexander M Aliper, Zeljka Smit-McBride, et al.
Cancer Medicine|April 3, 2014
A role for G-CSF and GM-CSF in nonmyeloid cancersAlexander M Aliper, Victoria P Frieden-Korovkina, Anton Buzdin, et al.
Aging|April 20, 2019
Replicative and radiation-induced aging: a comparison of gene expression profilesAlexander M Aliper, Marine E Bozdaganyan, Philipp S Orekhov, et al.
Oncotarget|October 9, 2014
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerAlexander M Aliper, Victoria P Frieden-Korovkina, Anton Buzdin, et al.
Reproductive Biology and Endocrinology : RB&E|June 15, 2014
Molecular aspects of development and regulation of endometriosisYana B Aznaurova, Marat B Zhumataev, Tiffany K Roberts, et al.
Aging|January 15, 2015
Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cellsAlexander M Aliper, Antonei Benjamin Csoka, Anton Buzdin, et al.
Drug Discovery Today|October 4, 2016
Design of efficient computational workflows for in silico drug repurposingQuentin Vanhaelen, Polina Mamoshina, Alexander M Aliper, et al.
Human Genome Variation|April 16, 2016
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patientsQingsong Zhu, Evgeny Izumchenko, Alexander M Aliper, et al.
Frontiers in Molecular Biosciences|May 20, 2015
The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysisAnton A Buzdin, Alex A Zhavoronkov, Mikhail B Korzinkin, et al.
Oncotarget|November 22, 2014
Signaling pathways activation profiles make better markers of cancer than expression of individual genesNikolay M Borisov, Nadezhda V Terekhanova, Alexander M Aliper, et al.
Pageof 2